Tempest Therapeutics Stock Investor Sentiment
| TPST Stock | USD 9.07 0.21 2.37% |
Slightly above 66 percent of all Tempest Therapeutics' private investors are curious in acquiring. The analysis of the overall investor sentiment regarding Tempest Therapeutics suggests that a large number of traders are confidant. Tempest Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Tempest Therapeutics' earnings reports, geopolitical events, and overall market trends.
Tempest Therapeutics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Tempest Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Tempest Therapeutics' Stock prices. Below is the latest headlines and news related to Tempest Therapeutics Stock. Current markets are strongly bearish. About 85% of major world exchanges and indexes are down. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Tempest Therapeutics that are available to investors today. This information is accessible both publicly - through Tempest Therapeutics' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Tempest-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Tempest Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Tempest Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Tempest Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Tempest Therapeutics alpha.
Tempest Largest EPS Surprises
Earnings surprises can significantly impact Tempest Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-06 | 2024-09-30 | -0.36 | -0.41 | -0.05 | 13 | ||
2025-03-17 | 2024-12-31 | -0.245 | -0.31 | -0.065 | 26 | ||
2023-11-08 | 2023-09-30 | -0.57 | -0.48 | 0.09 | 15 | ||
2023-05-10 | 2023-03-31 | -0.64 | -0.55 | 0.09 | 14 | ||
2023-03-22 | 2022-12-31 | -0.76 | -0.63 | 0.13 | 17 | ||
2022-08-15 | 2022-06-30 | -0.92 | -0.79 | 0.13 | 14 |
There is far too much social signal, news, headlines, and media speculation about Tempest Therapeutics that are available to investors today. This information is accessible both publicly - through Tempest Therapeutics' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Tempest-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Tempest Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Tempest Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Tempest Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Tempest Therapeutics alpha.
Tempest Therapeutics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Big Picture What is Tempest Therapeutics Inc. s P E ratio telling us - Trade Signal Summary Daily Stock Trend Watchlist - | 09/15/2025 |
2 | Acquisition by Whiting Samuel of 325000 shares of Tempest Therapeutics at 9.77 subject to Rule 16b-3 | 10/08/2025 |
3 | Will Tempest Therapeutics Inc. stock outperform Nasdaq index - 2025 Key Highlights Consistent Return Investment Signals - newser.com | 10/16/2025 |
4 | Ranking Tempest Therapeutics Inc. among high performing stocks via tools - July 2025 Analyst Calls Weekly Chart Analysis and Trade Guides - newser.com | 10/28/2025 |
5 | Tempest Therapeutics GAAP EPS of -0.79 beats by 2.48 | 11/05/2025 |
6 | Tempest Therapeutics Inc.s volatility index tracking explained - Long Setup Weekly Return Optimization Plans - newser.com | 11/11/2025 |
7 | Will Tempest Therapeutics Inc. stock go up soon - Weekly Trade Analysis Free Expert Approved Momentum Trade Ideas - newser.com | 11/14/2025 |
Additional Tools for Tempest Stock Analysis
When running Tempest Therapeutics' price analysis, check to measure Tempest Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tempest Therapeutics is operating at the current time. Most of Tempest Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tempest Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tempest Therapeutics' price. Additionally, you may evaluate how the addition of Tempest Therapeutics to your portfolios can decrease your overall portfolio volatility.